Resolute Capital Asset Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Sell |
160,672
-6,828
| -4% | -$1.18M | 14.49% | 1 |
|
|
2025
Q1 | $26.1M | Buy |
167,500
+53,000
| +46% | +$8.26M | 14.69% | 1 |
|
|
2024
Q4 | $15.8M | Buy |
114,500
+10,000
| +10% | +$1.38M | 8.48% | 3 |
|
|
2024
Q3 | $15.6M | Buy |
104,500
+57,500
| +122% | +$8.59M | 8.12% | 4 |
|
|
2024
Q2 | $6.41M | Hold |
47,000
| – | – | 3.69% | 9 |
|
|
2024
Q1 | $7.11M | Buy |
47,000
+10,600
| +29% | +$1.6M | 3.71% | 8 |
|
|
2023
Q4 | $4.59M | Sell |
36,400
-1,100
| -3% | -$139K | 2.99% | 10 |
|
|
2023
Q3 | $3.51M | Hold |
37,500
| – | – | 2.48% | 19 |
|
|
2023
Q2 | $3.35M | Hold |
37,500
| – | – | 2.38% | 18 |
|
|
2023
Q1 | $4.02M | Hold |
37,500
| – | – | 2.94% | 14 |
|
|
2022
Q4 | $4.58M | Buy |
37,500
+7,500
| +25% | +$916K | 4.09% | 10 |
|
|
2022
Q3 | $3.1M | Buy |
30,000
+10,000
| +50% | +$1.03M | 2.78% | 12 |
|
|
2022
Q2 | $1.86M | Hold |
20,000
| – | – | 1.34% | 25 |
|
|
2022
Q1 | $2.35M | Buy |
+20,000
| New | +$2.35M | 1.5% | 27 |
|